711 results on '"Moriguchi, J."'
Search Results
2. Natural Outcome of Isolated Right Ventricular Dysfunction Immediately After Heart Transplantation
3. Comparative analysis of von Willebrand factor profiles after implantation of left ventricular assist device and total artificial heart
4. Effects of a home-based exercise program on clinical outcomes in heart failure.
5. Effects of a Home-Based Exercise Program on Clinical Outcomes in Advanced Heart Failure
6. (575) The Outcome of Heart Transplant Patients with Severe Rejection Requiring ECMO Support: Is it Futile
7. (437) Extreme HLA Homozygosity Contributing to Extreme HLA Sensitization
8. (105) Clinical Outcomes of Heart Transplantation in Desensitized Durable Mechanical Circulatory Support Patients
9. (1169) Outcome of Enoxaparin Bridging in Left Ventricular Assist Devices (LVAD) in an Ambulatory Setting: A Continuation Study at Cedars Sinai Medical Center (CSMC)
10. (760) Is Chronic Kidney Disease Truly a Contraindication for Total Artificial Heart Candidacy and Subsequent Heart Transplantation
11. (792) Does Right Ventricular Support with Mechanical Assist Devices Compromise Outcome for Heart Transplantation?
12. (174) Do Older LVAD Patients Have Compromised Outcome after Heart Transplantation: Should They Stay as Destination Therapy?
13. Does Extracorporeal Membrane Oxygenation Duration as a Bridge to Total Artificial Heart Affect Outcomes
14. Determining Cause for Activated Partial Thromboplastin Time and Anti-Factor Xa Discordance in Mechanical Circulatory Support Patients on Heparin; Can Thromboelastogram Help?
15. Complexities of Explanting Durable LVADs (Done at Outside Facilities) at the Time of Heart Transplant Surgery
16. Extracorporeal Membrane Oxygenation as a Bridge to Total Artificial Hearts
17. Do Temporary Mechanical Circulatory Support Devices Activate Sensitization Pathways in Patients Awaiting Heart Transplantation?
18. (403) - Outcomes of Biopsy Negative but MMDx-Positive Biopsies After Heart Transplant: Are There Consequences?
19. (1107) - Monotherapy in Heart Transplantation Proves to Be Safe While Followed by T-Cell Immune Function Testing
20. (1070) - Natural Outcome of Isolated Right Ventricular Dysfunction Immediately After Heart Transplantation
21. Constructing Machine-learned Interatomic Potentials for Covalent Bonding Materials and MD Analyses of Dislocation and Surface
22. Comparative analysis of von Willebrand factor profiles in left ventricular assist device and total artificial heart recipients: OR216
23. Cyclosporine vs. Tacrolimus: Which Is a Better Match With Everolimus?: Abstract# C1601
24. How Old Is Too Old for Simultaneous Heart Kidney Donation?: Abstract# B1248
25. Tightly Controlled Diabetes By Hemoglobin A1c Does Not Appear to Neutralize the Adverse Effects of Diabetes On Outcomes After Left Ventricular Assist Device Placement.: Abstract# B1233
26. Freedom Driver With the Total Artificial Heart: A Single Center Experience.: Abstract# B1236
27. Complicated Ventricular Assist Device Patients With Good Post-Transplant Outcomes Supports 1A Upgrade.: Abstract# B1230
28. Perioperative Bleeding Risk of Anti-Platelet Therapy Prior to Heart Transplant.: Abstract# 1506
29. Single Center Experience of Total Artificial Heart as a Bridge to Heart Transplantation.: Abstract# 630
30. Heart Transplantation vs. Ventricular Assist Device as Destination Therapy in Older Patients: Are They Comparable?: Abstract# 626
31. Outcome of the Development of Early Restrictive Physiology after Heart Transplantation
32. Do Heart-Kidney Transplant Candidates on Mechanical Circulatory Support Have Acceptable Outcomes Post-Transplant?
33. Incidence of Heparin Induced Thrombocytopenia in Patients Undergoing Implantation of Durable and Non-Durable Mechanical Circulatory Support Devices
34. Landscape of Heart Transplantation Following Changes in UNOS Donor Allocation Policy
35. Outcomes after Heart Transplantation and Total Artificial Heart Implantation: A Multicenter Study
36. Heparin-Induced Thrombocytopenia and Thrombosis with Axillary Impella 5.5 as Bridge-to-Transplant
37. The Impact of Renal Dysfunction in Mechanical Circulatory Support Device Patients on Post-Heart Transplant Outcomes
38. The Effects of the New Donor Heart Allocation Policy on Temporary Device Utilization and Outcomes: A Single Center Experience
39. Early (1-Year) Class II Donor Specific Antibodies without Complement-Binding Appears Benign after Heart Transplantation
40. Incidence of Surgical-Related Infections in Temporary Mechanical Circulatory Support Patients Using Narrow Spectrum versus Broad Spectrum Peri-Operative Antibiotic Prophylaxis
41. A Bridged Approach to Heart Transplantation Using ECMO and Total Artificial Heart Implantation
42. Development and Validation of Specific Post-Transplant Risk Scores According to the Circulatory Support Status at Transplant: A UNOS Database Analysis
43. No meaningful increase in urinary tubular dysfunction markers in a population with 3μg cadmium/g creatinine in urine
44. Smoking-induced increase in urinary cadmium levels among Japanese women
45. Decreases in urine specific gravity and urinary creatinine in elderly women
46. Effects of aging on cadmium and tubular dysfunction markers in urine from adult women in non-polluted areas
47. Reproducibility of Urinary Cadmium, α1-Microglobulin, and β2-Microglobulin Levels in Health Screening of the General Population
48. No Effects of Hematuria and Proteinuria in School Days, and Probably Current Pregnancy and Current Lactation Also, as Risk Factors of Cadmium-Induced Renal Tubular Dysfunction Among Adult Women in General Populations in Japan
49. (128) Does Extracorporeal Membrane Oxygenation Duration as a Bridge to Total Artificial Heart Affect Outcomes
50. No significant effect of iron deficiency on cadmium body burden or kidney dysfunction among women in the general population in Japan
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.